Christopher Stevens, MD
Otolaryngology · Columbus, INNPI 1093712291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by GSK at 47.4% of the total. Reporting peaked in 2022 at $344 and has fallen 65.2% since, to $120 in 2025. That places this record below the midpoint for otolaryngology clinicians in IN, where the typical reported total is $1,447.
Across 36 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$357
- Regeneron Healthcare Solutions, Inc.$113
- AbbVie$104
- Optinose US, Inc.$63
- Pacira Pharmaceuticals Incorporated$25
- Inspire Medical Systems, Inc.$22
- plus $69 from 5 others
What the payments were for
- Food & beverage$753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 17 | $357 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| AbbVie | 5 | $104 |
| Optinose US, Inc. | 2 | $63 |
| Pacira Pharmaceuticals Incorporated | 2 | $25 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $18 |
| Acclarent, Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Trevena, Inc. | 1 | $12 |
| Xoran Technologies LLC | 1 | $10 |
How this compares
$753 in reported general payments places this provider in the 35th percentile of 193 otolaryngology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 298 | $6,385 |
| Cefdinir | 138 | $3,060 |
| Levothyroxine Sodium | 257 | $2,507 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 51 | $2,381 |
| SynthroidLevothyroxine Sodium | 29 | $1,979 |
| Ciprofloxacin Hcl | 100 | $1,092 |
| Ipratropium Bromide | 44 | $993 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $794 |
| Clarithromycin | 17 | $584 |
| Fluticasone Propionate | 50 | $501 |
| Omeprazole | 60 | $489 |
| Doxycycline Hyclate | 54 | $476 |
| Montelukast Sodium | 54 | $279 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $224 |
| Calcitriol | 16 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $104 | $1,97929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 193 otolaryngology providers in Indiana.
Other otolaryngology in Columbus
- Nicholas HollenkampColumbus$10K
- Anthony SandersColumbus$8K
- Joshua GreeneAnderson$955K
- Satyan SreenathIndianapolis$103K
- Stephen FreemanCarmel$33K
- Venkata KakarlapudiNew Albany$33K
- Elisa IllingIndianapolis$28K
- Colin NeumannNew Albany$26K
- Erin KevernElkhart$26K
- Aaron DubersteinLafayette$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.